0069-0284 : Ibrance 75 mg Oral Tablet, Film Coated


NDC0069-0284
Labeler: Pfizer Laboratories Div Pfizer Inc
Product Type: Human Prescription Drug
Drug Name:  Ibrance
Dosage Form: Oral Tablet, Film Coated
Application #: NDA212436
Rev. Date: 


NDC Package Codes:

  • 0069-0284-03: 3 DOSE PACK IN 1 CARTON (0069‑0284‑03) > 7 TABLET, FILM COATED IN 1 DOSE PACK (0069‑0284‑07)

Active Ingredients:

  • Palbociclib

Dosage Strength:

  • 75 mg

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Kinase Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0069-0187 Ibrance 75 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 0069-0188 Ibrance 100 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 0069-0189 Ibrance 125 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 0069-0486 Ibrance 100 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
  • 0069-0688 Ibrance 125 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
  • 63539-187 Ibrance 75 mg Oral Capsule by U.S. Pharmaceuticals
  • 63539-188 Ibrance 100 mg Oral Capsule by U.S. Pharmaceuticals
  • 63539-189 Ibrance 125 mg Oral Capsule by U.S. Pharmaceuticals
  • 63539-284 Ibrance 75 mg Oral Tablet, Film Coated by Us Pharmaceuticals
  • 63539-486 Ibrance 100 mg Oral Tablet, Film Coated by Us Pharmaceuticals
  • 63539-688 Ibrance 125 mg Oral Tablet, Film Coated by Us Pharmaceuticals

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0069-0284 QR Code

< Prev: 0069-0249Next: 0069-0291 >




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.